1	Nuclear	nuclear	_	_	_	_	_	_	_
2	factor	factor	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	activated	activate	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	AP-1	ap-1	_	_	_	_	_	_	_
9	are	be	_	_	_	_	_	_	_
10	insufficient	insufficient	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	IL-2	il-2	_	_	_	_	_	_	_
13	promoter	promoter	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	:	:	_	_	_	_	_	_	_
16	requirement	requirement	_	_	_	_	_	_	_
17	for	for	_	_	_	_	_	_	_
18	CD28	cd28	_	_	_	_	_	_	_
19	up-regulation	up-regulation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	RE/AP	RE/AP	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	IL-2	il-2	_	_	_	_	_	_	_
2	gene	gene	_	_	_	_	_	_	_
3	transcription	transcription	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	requires	require	_	_	_	_	_	_	_
8	both	both	_	_	_	_	_	_	_
9	TCR	TCR	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	costimulatory	costimulatory	_	_	_	_	_	_	_
12	signals	signal	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	IL-2	il-2	_	_	_	_	_	_	_
2	promoter	promoter	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	Jurkat	Jurkat	_	_	_	_	_	_	_
6	T	t	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	stimulated	stimulate	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	superantigen	superantigen	_	_	_	_	_	_	_
11	presented	present	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	Raji	Raji	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	requires	require	_	_	_	_	_	_	_
17	CD28	cd28	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	rCTLA4Ig	rctla4ig	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	which	which	_	_	_	_	_	_	_
7	blocks	block	_	_	_	_	_	_	_
8	CD28	cd28	_	_	_	_	_	_	_
9	binding	binding	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	its	its	_	_	_	_	_	_	_
12	ligand	ligand	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	cultures	culture	_	_	_	_	_	_	_
17	decreased	decrease	_	_	_	_	_	_	_
18	IL-2	il-2	_	_	_	_	_	_	_
19	promoter	promoter	_	_	_	_	_	_	_
20	activation	activation	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	>80	>80	_	_	_	_	_	_	_
23	%	%	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Interestingly	interestingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	CTLA4Ig	CTLA4Ig	_	_	_	_	_	_	_
4	did	do	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	significantly	significantly	_	_	_	_	_	_	_
7	inhibit	inhibit	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	either	either	_	_	_	_	_	_	_
12	NF	nf	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	activated	activate	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	NFAT	NFAT	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	AP-1	ap-1	_	_	_	_	_	_	_
22	reporters	reporter	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Therefore	therefore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NFAT	NFAT	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	AP-1	ap-1	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	insufficient	insufficient	_	_	_	_	_	_	_
10	for	for	_	_	_	_	_	_	_
11	IL-2	il-2	_	_	_	_	_	_	_
12	promoter	promoter	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	an	an	_	_	_	_	_	_	_
5	RE/AP	RE/AP	_	_	_	_	_	_	_
6	reporter	reporter	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	blocked	block	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	CTLA4Ig	ctla4ig	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	>90	>90	_	_	_	_	_	_	_
13	%	%	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	requirement	requirement	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	CD28	cd28	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	IL-2	il-2	_	_	_	_	_	_	_
9	promoter	promoter	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	appears	appear	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	be	be	_	_	_	_	_	_	_
14	due	due	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	RE/AP	RE/AP	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	not	not	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	NFAT	nfat	_	_	_	_	_	_	_
21	or	or	_	_	_	_	_	_	_
22	AP-1	ap-1	_	_	_	_	_	_	_
23	sites	site	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	these	these	_	_	_	_	_	_	_
5	data	datum	_	_	_	_	_	_	_
6	suggest	suggest	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	transcriptional	transcriptional	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	RE/AP	RE/AP	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	mediated	mediate	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	NFAT	NFAT	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	because	because	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	NFAT	NFAT	_	_	_	_	_	_	_
23	reporter	reporter	_	_	_	_	_	_	_
24	is	be	_	_	_	_	_	_	_
25	not	not	_	_	_	_	_	_	_
26	affected	affect	_	_	_	_	_	_	_
27	by	by	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	addition	addition	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	CTLA4Ig	CTLA4Ig	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

